Literature DB >> 24661380

Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine.

Adeline Cathala1, Céline Devroye, Marlène Maitre, Pier Vincenzo Piazza, Djoher Nora Abrous, Jean-Michel Revest, Umberto Spampinato.   

Abstract

In keeping with its ability to control the mesoaccumbens dopamine (DA) pathway, the serotonin2C receptor (5-HT2C R) plays a key role in mediating the behavioral and neurochemical effects of drugs of abuse. Studies assessing the influence of 5-HT2C R agonists on cocaine-induced responses have suggested that 5-HT2C Rs can modulate mesoaccumbens DA pathway activity independently of accumbal DA release, thereby controlling DA transmission in the nucleus accumbens (NAc). In the present study, we assessed this hypothesis by studying the influence of the 5-HT2C R agonist Ro 60-0175 on cocaine-induced behavioral, neurochemical and molecular responses. The i.p. administration of 1 mg/kg Ro 60-0175 inhibited hyperlocomotion induced by cocaine (15 mg/kg, i.p.), had no effect on cocaine-induced DA outflow in the shell, and increased it in the core subregion of the NAc. Furthermore, Ro 60-0175 inhibited the late-onset locomotion induced by the subcutaneous administration of the DA-D2 R agonist quinpirole (0.5 mg/kg), as well as cocaine-induced increase in c-Fos immunoreactivity in NAc subregions. Finally, Ro 60-0175 inhibited cocaine-induced phosphorylation of the DA and c-AMP regulated phosphoprotein of Mr 32 kDa (DARPP-32) at threonine residues in the NAc core, this effect being reversed by the selective 5-HT2C R antagonist SB 242084 (0.5 mg/kg, i.p.). Altogether, these findings demonstrate that 5-HT2C Rs are capable of modulating mesoaccumbens DA pathway activity at post-synaptic level by specifically controlling DA signaling in the NAc core subregion. In keeping with the tight relationship between locomotor activity and NAc DA function, this interaction could participate in the inhibitory control of cocaine-induced locomotor activity.
© 2014 Society for the Study of Addiction.

Entities:  

Keywords:  5-HT2C receptor; DARPP-32; c-Fos; dopamine release; locomotor activity; nucleus accumbens

Mesh:

Substances:

Year:  2014        PMID: 24661380     DOI: 10.1111/adb.12137

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  9 in total

Review 1.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

2.  Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats.

Authors:  Clayton T Bauer; Matthew L Banks; Bruce E Blough; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2015-06-05       Impact factor: 4.530

3.  Repeated 7-Day Treatment with the 5-HT2C Agonist Lorcaserin or the 5-HT2A Antagonist Pimavanserin Alone or in Combination Fails to Reduce Cocaine vs Food Choice in Male Rhesus Monkeys.

Authors:  Matthew L Banks; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2016-11-18       Impact factor: 7.853

4.  Cocaine increases stimulation-evoked serotonin efflux in the nucleus accumbens.

Authors:  Jason Yuen; Abhinav Goyal; Aaron E Rusheen; Abbas Z Kouzani; Michael Berk; Jee Hyun Kim; Susannah J Tye; Charles D Blaha; Kevin E Bennet; Kendall H Lee; Yoonbae Oh; Hojin Shin
Journal:  J Neurophysiol       Date:  2022-01-05       Impact factor: 2.714

Review 5.  "Selective" serotonin 5-HT2A receptor antagonists.

Authors:  Austen B Casey; Meng Cui; Raymond G Booth; Clinton E Canal
Journal:  Biochem Pharmacol       Date:  2022-04-04       Impact factor: 6.100

6.  New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties.

Authors:  Chungping Yu; Jennie Garcia-Olivares; Shawn Candler; Stefan Schwabe; Vladimir Maletic
Journal:  J Exp Pharmacol       Date:  2020-08-25

7.  The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites.

Authors:  Elena K Schneider; Rachel M McQuade; Vincenzo C Carbone; Felisa Reyes-Ortega; John W Wilson; Brenda Button; Ayame Saito; Daniel P Poole; Daniel Hoyer; Jian Li; Tony Velkov
Journal:  ERJ Open Res       Date:  2018-03-13

Review 8.  The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.

Authors:  Clinton E Canal; Kevin S Murnane
Journal:  J Psychopharmacol       Date:  2016-11-15       Impact factor: 4.153

9.  Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice.

Authors:  Adele Stewart; Gwynne L Davis; Paul J Gresch; Rania M Katamish; Rodeania Peart; Maximilian J Rabil; Raajaram Gowrishankar; F Ivy Carroll; Maureen K Hahn; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2018-12-21       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.